Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.66)
# 803
Out of 5,111 analysts
137
Total ratings
55.22%
Success rate
4.81%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Outperform | $18 → $12 | $3.89 | +208.48% | 1 | Nov 12, 2025 | |
| HCA HCA Healthcare | Maintains: Outperform | $400 → $500 | $470.39 | +6.29% | 12 | Oct 27, 2025 | |
| GRDN Guardian Pharmacy Services | Initiates: Outperform | $30 | $29.53 | +1.59% | 1 | Oct 10, 2025 | |
| CHE Chemed | Maintains: Outperform | $650 → $580 | $423.79 | +36.86% | 13 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $400 → $325 | $336.40 | -3.39% | 17 | Jul 30, 2025 | |
| CNC Centene | Maintains: Outperform | $51 → $43 | $41.78 | +2.92% | 19 | Jul 28, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $264.48 | +17.21% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $279.12 | +34.35% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $7.05 | +70.21% | 11 | Jan 24, 2025 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $27.84 | +32.90% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $165 → $168 | $173.91 | -3.40% | 8 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $106.58 | +36.05% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $39.51 | +1.24% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.10 | +61.29% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $9.09 | - | 2 | Mar 7, 2024 |
Evolent Health
Nov 12, 2025
Maintains: Outperform
Price Target: $18 → $12
Current: $3.89
Upside: +208.48%
HCA Healthcare
Oct 27, 2025
Maintains: Outperform
Price Target: $400 → $500
Current: $470.39
Upside: +6.29%
Guardian Pharmacy Services
Oct 10, 2025
Initiates: Outperform
Price Target: $30
Current: $29.53
Upside: +1.59%
Chemed
Jul 31, 2025
Maintains: Outperform
Price Target: $650 → $580
Current: $423.79
Upside: +36.86%
UnitedHealth Group
Jul 30, 2025
Maintains: Outperform
Price Target: $400 → $325
Current: $336.40
Upside: -3.39%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51 → $43
Current: $41.78
Upside: +2.92%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $264.48
Upside: +17.21%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $279.12
Upside: +34.35%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $7.05
Upside: +70.21%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $27.84
Upside: +32.90%
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $173.91
Upside: -3.40%
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $106.58
Upside: +36.05%
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $39.51
Upside: +1.24%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.10
Upside: +61.29%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $9.09
Upside: -